Invention Grant
US08575307B2 Protein kinase C inhibitors for prevention of insulin resistance and type 2 diabetes
有权
用于预防胰岛素抵抗和2型糖尿病的蛋白激酶C抑制剂
- Patent Title: Protein kinase C inhibitors for prevention of insulin resistance and type 2 diabetes
- Patent Title (中): 用于预防胰岛素抵抗和2型糖尿病的蛋白激酶C抑制剂
-
Application No.: US11993691Application Date: 2006-06-28
-
Publication No.: US08575307B2Publication Date: 2013-11-05
- Inventor: Eleazar Shafrir , Ehud Ziv , Hadas Reuveni , Masha Niv
- Applicant: Eleazar Shafrir , Ehud Ziv , Hadas Reuveni , Masha Niv
- Applicant Address: IL Jerusalem
- Assignee: Hadasit Medical Research Services & Development Ltd.
- Current Assignee: Hadasit Medical Research Services & Development Ltd.
- Current Assignee Address: IL Jerusalem
- Agency: Rothwell, Figg, Ernst & Manbeck, P.C.
- International Application: PCT/IL2006/000755 WO 20060628
- International Announcement: WO2007/000770 WO 20070104
- Main IPC: A61K38/04
- IPC: A61K38/04 ; A61K38/00 ; A61K38/28 ; C07K5/00 ; C07K7/00 ; C07K16/00 ; C07K17/00 ; C07K2/00 ; C07K4/00 ; C07K14/00 ; A61P3/08 ; A61P3/10 ; A61P5/50 ; A61P7/12
Abstract:
The present invention provides peptides and peptide analogs capable of inhibiting the activity of protein kinase C. The invention discloses use of such peptides and analogs for preparation of pharmaceutical compositions and methods for prevention, delay, suppression or treatment of type 2 diabetes using such compositions.
Public/Granted literature
- US20100216701A1 Protein Kinase C Inhibitors for Prevention of Insulin Resistance and Type 2 Diabetes Public/Granted day:2010-08-26
Information query
IPC分类:
